Total Diversity Clinical Trial Management
- Company typePrivate
- Founded1970
- HeadquartersDallas, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
Total Diversity Clinical Trial Management firmographics
Firmographics- Name
- Total Diversity Clinical Trial Management
- Legal name
- Total Trials Inc.
- Website
- https://totaldiversity.com
- Company type
- Private
- Founded year
- 1970
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Total Diversity Clinical Trial Management industry classification
Industry- Product category
- Contract Research Organization (CRO) Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Clinical Trial Site Operations & Study Coordination (HLAGACAE), Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)
Keywords
Where Total Diversity Clinical Trial Management is headquartered
LocationHeadquarters
- HQ city
- Dallas
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Total Diversity Clinical Trial Management business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Full-Service CRO Services: Provides end-to-end trial management from protocol design and site selection to study execution and final analysis. Revenue generated through project-based fees for comprehensive clinical trial management services.
- Functional Service Provider (FSP) Support: Provides right-sized single service solutions allowing sponsors to scale clinical trial support as needed. Revenue generated through service agreements for specific functional support.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels3 records
Total Diversity Clinical Trial Management product offering
Product offeringCore offering
Total Diversity Clinical Trial Management is a contract research organization (CRO) that provides end-to-end clinical trial management services with a specialization in diversity-focused patient recruitment and enrollment for U.S. clinical trials. The firm delivers both full-service CRO capabilities and functional service provider (FSP) support to pharmaceutical, biotech, government, and academic clients.
Product overview
Total Trials operates as a full-service Contract Research Organization (CRO) offering a comprehensive suite of clinical research services through multiple delivery models: Full-Service CRO, Functional Service Provider (FSP) Support, and specialized services. The company provides end-to-end trial management from protocol design through final analysis. Total Diversity Clinical Trial Management represents a specialized brand within the Total Trials portfolio, focusing on US clinical trial capabilities and patient recruitment services. The portfolio includes solutions tailored for infectious diseases, oncology, and approximately 20 other therapeutic areas, supported by a database of over 1000 research-ready sites across more than 70 countries.
Differentiator
Problem solved
Functional benefit
Products and services
- Full-Service CRO End-to-end clinical trial management for sponsors, covering study design, site management, monitoring, regulatory support, and trial closeout for pharmaceutical, biotech, government, and academic clients.
- Functional Service Provider (FSP) Support Flexible resourcing model providing targeted functional support (such as monitoring, data management, or site coordination) that integrates into a sponsor's in-house clinical operations team.
- Diversity-Focused Patient Recruitment Specialized patient recruitment and enrollment service designed to increase representation of diverse populations in U.S. clinical trials, addressing common enrollment and demographic challenges.
Quantifiable outcome
- 500+ Clinical Studies Supported
- +2 more outcomes
Companies that use Total Diversity Clinical Trial Management
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
Total Diversity Clinical Trial Management technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Total Diversity Clinical Trial Management partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Total Trials (Parent Organization)coreTotal Diversity Clinical Trial Management was integrated into Total Trials (formerly FHI Clinical) on May 1, 2026, strengthening Total Trials' US clinical trial capabilities and patient recruitment services. This integration enhances Total Trials' position as a leading CRO with expanded US market presence.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Total Diversity Clinical Trial Management competitors and assessment
Company assessmentBroad incumbents
- Labcorp (Covance): Labcorp's Covance clinical development arm offers full-service CRO plus central laboratory services globally. Comparable as a broad incumbent with combined clinical trial management and diagnostic/laboratory capabilities for pharma/biotech sponsors.
- IQVIA: IQVIA is the world's largest CRO offering full-service clinical trial management, FSP, and real-world evidence services globally. Comparable as the dominant incumbent CRO against which all mid-size competitors, including Total Diversity/Total Trials, compete for sponsor contracts.
- ICON plc: ICON is a top-3 global CRO providing full-service clinical research, FSP, and laboratory services across all major therapeutic areas. Comparable as a broad incumbent offering end-to-end clinical trial management that competes for the same pharma/biotech sponsor wallet.
- Parexel International: Parexel is a large global CRO with strong biopharma focus and expertise across multiple therapeutic areas. Comparable as a full-service CRO serving pharma/biotech sponsors with similar end-to-end clinical trial delivery capabilities.
- Charles River Laboratories: Charles River provides preclinical and clinical research services including CRO solutions and site management. Comparable as a broad life sciences research services provider with overlapping clinical trial management capabilities and similar enterprise biotech/pharma customers.
Direct peers
- Medpace: Medpace is a mid-to-large full-service CRO focused on therapeutic expertise-driven execution across all trial phases. Comparable as a CRO with similar full-service and FSP delivery models targeting biotech and pharma sponsors, though with greater scale and broader therapeutic mix.
- Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized CRO with therapeutic expertise in neuroscience, oncology, and rare diseases. Comparable as a similarly-sized CRO offering full-service and FSP models with comparable sponsor profiles and competitive positioning.
- Syneos Health: Syneos Health is a mid-to-large full-service CRO and contract commercial organization offering clinical development and commercialization services. Comparable as a similarly-positioned CRO with full-service and FSP delivery models targeting pharma/biotech sponsors.
Emerging players
- Clinipace Worldwide: Clinipace is a mid-sized CRO providing clinical trial services across multiple therapeutic areas including oncology and rare disease. Comparable as a similarly-sized CRO with overlapping therapeutic breadth and comparable mid-market sponsor clients.
Others
- WCG (WIRB-Copernicus Group): WCG provides clinical trial enablement services including IRB review, technology platforms, and site optimization. Comparable as an enabling ecosystem participant in clinical research, though focused on trial operations support rather than direct CRO services.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Total Diversity Clinical Trial Management social profiles
Digital presenceTotal Diversity Clinical Trial Management financial estimates
Financial estimateRevenue estimate
Valuation estimate
Total Diversity Clinical Trial Management leadership team
Management profileNumber of profiles
Profiles1 record
Total Diversity Clinical Trial Management funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Total Diversity Clinical Trial Management M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Total Diversity Clinical Trial Management
What does Total Diversity Clinical Trial Management do?
Total Diversity Clinical Trial Management is a contract research organization (CRO) that provides end-to-end clinical trial management services with a specialization in diversity-focused patient recruitment and enrollment for U.S. clinical trials. The firm delivers both full-service CRO capabilities and functional service provider (FSP) support to pharmaceutical, biotech, government, and academic clients.
Is Total Diversity Clinical Trial Management a public or private company?
Total Diversity Clinical Trial Management is a private company. It is classified as corporate owned and is currently operating.
When was Total Diversity Clinical Trial Management founded?
Total Diversity Clinical Trial Management was founded in 1970. It employs 11 to 50 people.
Where is Total Diversity Clinical Trial Management based?
Total Diversity Clinical Trial Management is headquartered in Dallas, United States, in the North America region.
How does Total Diversity Clinical Trial Management make money?
Two revenue lines are on record. Full-Service CRO Services are the primary driver. The others are functional Service Provider (FSP) Support.
Who are Total Diversity Clinical Trial Management's main competitors?
Broad incumbents on record are Labcorp (Covance), IQVIA, ICON plc, Parexel International and Charles River Laboratories. Direct peers are Medpace, Worldwide Clinical Trials and Syneos Health. Clinipace Worldwide is listed as an emerging player. WCG (WIRB-Copernicus Group) is listed as an others.
Does Total Diversity Clinical Trial Management have an API?
No public API is recorded for Total Diversity Clinical Trial Management.
What industry is Total Diversity Clinical Trial Management in?
Total Diversity Clinical Trial Management's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs. Its NAICS code is 5417 and its SIC code is 8731.